VTv Total Liab vs Other Current Assets Analysis

VTVT Stock  USD 14.18  0.65  4.38%   
VTv Therapeutics financial indicator trend analysis is much more than just breaking down vTv Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether vTv Therapeutics is a good investment. Please check the relationship between VTv Therapeutics Total Liab and its Other Current Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in vTv Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.

Total Liab vs Other Current Assets

Total Liab vs Other Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of vTv Therapeutics Total Liab account and Other Current Assets. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between VTv Therapeutics' Total Liab and Other Current Assets is -0.55. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Other Current Assets in the same time period over historical financial statements of vTv Therapeutics, assuming nothing else is changed. The correlation between historical values of VTv Therapeutics' Total Liab and Other Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of vTv Therapeutics are associated (or correlated) with its Other Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Assets has no effect on the direction of Total Liab i.e., VTv Therapeutics' Total Liab and Other Current Assets go up and down completely randomly.

Correlation Coefficient

-0.55
Relationship DirectionNegative 
Relationship StrengthVery Weak

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.
Most indicators from VTv Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into vTv Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in vTv Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.At this time, VTv Therapeutics' Issuance Of Capital Stock is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 11.59 in 2024, whereas Selling General Administrative is likely to drop slightly above 11.5 M in 2024.
 2021 2022 2023 2024 (projected)
Interest Expense12K15K13K12.4K
Depreciation And Amortization89K92K90K85.5K

VTv Therapeutics fundamental ratios Correlations

-0.150.18-0.270.23-0.25-0.28-0.02-0.670.460.350.96-0.34-0.04-0.11-0.180.960.310.85-0.33-0.02-0.440.150.11-0.08-0.3
-0.15-0.610.95-0.79-0.390.96-0.070.82-0.31-0.02-0.270.780.81-0.81-0.2-0.26-0.26-0.3-0.190.630.02-0.3-0.850.780.95
0.18-0.61-0.510.59-0.02-0.740.57-0.530.430.660.23-0.56-0.370.530.120.230.550.290.05-0.52-0.020.020.69-0.58-0.73
-0.270.95-0.51-0.61-0.480.9-0.110.86-0.15-0.03-0.370.730.67-0.63-0.39-0.37-0.25-0.4-0.170.390.13-0.16-0.660.580.91
0.23-0.790.59-0.61-0.1-0.83-0.18-0.710.770.10.33-0.75-0.810.77-0.420.320.260.370.14-0.960.070.560.98-0.99-0.82
-0.25-0.39-0.02-0.48-0.1-0.230.13-0.14-0.64-0.34-0.2-0.27-0.260.360.72-0.20.16-0.17-0.10.19-0.440.010.010.06-0.18
-0.280.96-0.740.9-0.83-0.23-0.180.87-0.47-0.26-0.390.840.72-0.73-0.1-0.39-0.34-0.41-0.270.670.02-0.23-0.880.810.99
-0.02-0.070.57-0.11-0.180.13-0.180.01-0.210.61-0.090.060.28-0.020.48-0.090.33-0.230.150.230.09-0.42-0.050.18-0.19
-0.670.82-0.530.86-0.71-0.140.870.01-0.5-0.23-0.770.820.61-0.51-0.04-0.77-0.27-0.740.020.480.27-0.23-0.680.620.87
0.46-0.310.43-0.150.77-0.64-0.47-0.21-0.50.40.5-0.47-0.330.24-0.750.50.20.50.13-0.770.150.380.66-0.71-0.48
0.35-0.020.66-0.030.1-0.34-0.260.61-0.230.40.36-0.280.36-0.220.030.360.370.370.11-0.05-0.01-0.480.13-0.05-0.26
0.96-0.270.23-0.370.33-0.2-0.39-0.09-0.770.50.36-0.53-0.13-0.02-0.161.00.180.92-0.28-0.11-0.450.070.21-0.19-0.39
-0.340.78-0.560.73-0.75-0.270.840.060.82-0.47-0.28-0.530.61-0.610.03-0.53-0.2-0.59-0.080.610.29-0.1-0.750.720.8
-0.040.81-0.370.67-0.81-0.260.720.280.61-0.330.36-0.130.61-0.930.14-0.13-0.18-0.19-0.010.750.0-0.63-0.840.820.71
-0.11-0.810.53-0.630.770.36-0.73-0.02-0.510.24-0.22-0.02-0.61-0.93-0.04-0.020.220.010.0-0.75-0.010.530.85-0.82-0.7
-0.18-0.20.12-0.39-0.420.72-0.10.48-0.04-0.750.03-0.160.030.14-0.04-0.160.13-0.120.010.56-0.24-0.45-0.280.4-0.1
0.96-0.260.23-0.370.32-0.2-0.39-0.09-0.770.50.361.0-0.53-0.13-0.02-0.160.180.92-0.28-0.11-0.450.070.21-0.18-0.39
0.31-0.260.55-0.250.260.16-0.340.33-0.270.20.370.18-0.2-0.180.220.130.180.28-0.22-0.18-0.280.320.31-0.22-0.35
0.85-0.30.29-0.40.37-0.17-0.41-0.23-0.740.50.370.92-0.59-0.190.01-0.120.920.28-0.29-0.17-0.470.050.27-0.24-0.42
-0.33-0.190.05-0.170.14-0.1-0.270.150.020.130.11-0.28-0.08-0.010.00.01-0.28-0.22-0.29-0.170.6-0.240.19-0.19-0.3
-0.020.63-0.520.39-0.960.190.670.230.48-0.77-0.05-0.110.610.75-0.750.56-0.11-0.18-0.17-0.17-0.18-0.58-0.940.980.65
-0.440.02-0.020.130.07-0.440.020.090.270.15-0.01-0.450.290.0-0.01-0.24-0.45-0.28-0.470.6-0.18-0.190.12-0.13-0.04
0.15-0.30.02-0.160.560.01-0.23-0.42-0.230.38-0.480.07-0.1-0.630.53-0.450.070.320.05-0.24-0.58-0.190.48-0.55-0.22
0.11-0.850.69-0.660.980.01-0.88-0.05-0.680.660.130.21-0.75-0.840.85-0.280.210.310.270.19-0.940.120.48-0.98-0.86
-0.080.78-0.580.58-0.990.060.810.180.62-0.71-0.05-0.190.720.82-0.820.4-0.18-0.22-0.24-0.190.98-0.13-0.55-0.980.79
-0.30.95-0.730.91-0.82-0.180.99-0.190.87-0.48-0.26-0.390.80.71-0.7-0.1-0.39-0.35-0.42-0.30.65-0.04-0.22-0.860.79
Click cells to compare fundamentals

VTv Therapeutics Account Relationship Matchups

VTv Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets9.3M14.8M25.5M33.2M11.0M10.5M
Short Long Term Debt Total7.1M915K932K716K529K502.6K
Other Current Liab4.8M4.0M6.0M4.7M6.0M5.7M
Total Current Liabilities13.4M6.4M8.5M7.7M10.6M15.0M
Total Stockholder Equity(49.0M)(80.1M)(9.7M)(10.7M)(24.7M)(25.9M)
Other Liab3.9M3.9M1.3M19.4M17.4M18.3M
Property Plant And Equipment Net1.0M849K680K556K361K343.0K
Net Debt5.3M(4.8M)(12.5M)(11.4M)(8.9M)(8.5M)
Retained Earnings(233.5M)(290.0M)(248.8M)(265.5M)(281.0M)(295.1M)
Accounts Payable7.1M1.9M1.9M2.5M4.1M4.8M
Cash1.8M5.7M13.4M12.1M9.4M14.4M
Non Current Assets Total6.4M7.6M9.9M6.1M361K343.0K
Non Currrent Assets Other2.5M2.9M(7.6M)(6.1M)(5.5M)(5.3M)
Other Assets4.8M2.5M2.9M7.2M8.3M8.7M
Cash And Short Term Investments1.8M5.7M13.4M12.1M9.4M14.4M
Net Receivables5K158K57K12.4M102K96.9K
Common Stock Shares Outstanding757.3K1.2M1.6M1.9M2.1M1.9M
Short Term Investments250K371K100K15K65K61.8K
Liabilities And Stockholders Equity9.3M14.8M25.5M33.2M11.0M10.5M
Non Current Liabilities Total44.9M88.5M26.7M36.3M18.9M18.0M
Other Current Assets806K939K2.1M2.5M1.1M1.1M
Other Stockholder Equity183.9M209.2M238.2M254.8M256.3M269.2M
Total Liab58.3M94.9M35.2M44.0M29.6M28.1M
Property Plant And Equipment Gross1.0M367K680K556K848K1.1M
Total Current Assets2.8M7.2M15.6M27.1M10.7M16.9M
Short Term Debt6.3M394K624K532K529K502.6K
Property Plant Equipment1.0M367K680K207K186.3K177.0K
Net Tangible Assets(49.0M)3.8M(9.7M)5.8M6.7M7.1M
Short Long Term Debt6.2M84K256K224K191K181.5K
Common Stock Total Equity435K641K541K1.0M1.2M1.3M
Capital Surpluse150.6M183.9M209.2M253.7M291.8M183.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for VTv Stock Analysis

When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.